Drug Research

Stem Cell Plan To Vision Recovery – Singapore, Sweden Study

Preclinical study making use of stem cells to develop progenitor photoreceptor cells-light detecting cells found in the eye and thereafter transplanting these cells into experimental models of damaged retinas has led to a significant recovery of the vision. The findings...

Traditional Chinese Drug Helps Mice Survive Brain Tumour

A new study demonstrates how a medication derived from a natural component used in classical Chinese medicine works over malignant brain tumours in mice, opening up a new path of investigation for glioblastoma treatment. Researchers demonstrated how indirubin, a formulation...

Human Lungs Created To Test Drugs By Australian Scientists

University of Australia scientists, with collaborators from South Korea, China, and, of course, Australia, have gone on to develop a step-wise blueprint so as to create advanced human lung models in the lab, which, according to them, is going...

Cognizant, Boehringer Collaborate on Unified Cloud Platform to Speed Drug Development

Cognizant is working with Boehringer Ingelheim, a research-driven biopharmaceutical company, to advance the speed and quality of medicinal therapy development. Leveraging the Veeva Development Cloud, Cognizant will help Boehringer Ingelheim to unify medicinal development processes and data into a...

Wheeler Bio $31M in Financing to Support Clinical Drug Substance Mfg. Facility

Wheeler Bio, Inc., a CDMO specializing in process development and small batch cGMP production of therapeutic antibodies, announced the closing of their Series A financing round. The company will use the funding to complete its state-of-the-art cGMP cell banking...

Araris Biotech AG Announces Strategic Investment with Samsung Ventures

Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology,announced that Samsung Venture Investment Corporation (“Samsung Ventures”), an investment corporation established to promote the development of new technologies, has invested in the Company in an independent deal...

CBM Completes Tech Transfer for Manufacturing Platform for AAV Production

The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges associated with the commercialization of cell and gene therapies, has completed a successful technology transfer of the University of Pennsylvania Gene...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read